Ritesh Rathore

1.3k total citations
44 papers, 1.0k citations indexed

About

Ritesh Rathore is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ritesh Rathore has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ritesh Rathore's work include CAR-T cell therapy research (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Ritesh Rathore is often cited by papers focused on CAR-T cell therapy research (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Ritesh Rathore collaborates with scholars based in United States and Canada. Ritesh Rathore's co-authors include Lawrence G. Lum, Howard Safran, David A. Iannitti, Archana Thakur, Nicola Kouttab, Anthony J. Bais, Robin Davies, Richard P. Junghans, Mehrdad Abedi and Erica M. Gomes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ritesh Rathore

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritesh Rathore United States 15 837 242 239 221 217 44 1.0k
Leonid Dubrovsky United States 12 828 1.0× 272 1.1× 399 1.7× 160 0.7× 294 1.4× 29 1.6k
Martin Kornacker Germany 20 564 0.7× 160 0.7× 399 1.7× 123 0.6× 380 1.8× 59 1.3k
Max M. Wattenberg United States 14 843 1.0× 251 1.0× 505 2.1× 148 0.7× 240 1.1× 25 1.2k
James G. Jakowatz United States 16 602 0.7× 124 0.5× 268 1.1× 145 0.7× 342 1.6× 44 948
Dalong Wan China 12 439 0.5× 240 1.0× 137 0.6× 256 1.2× 280 1.3× 30 1.1k
Antonio Cubillo Spain 18 864 1.0× 253 1.0× 118 0.5× 74 0.3× 208 1.0× 88 1.1k
Hazel Jones United Kingdom 4 925 1.1× 432 1.8× 409 1.7× 115 0.5× 155 0.7× 7 1.3k
Sylvie Rusakiewicz France 22 800 1.0× 168 0.7× 800 3.3× 98 0.4× 322 1.5× 44 1.4k
Edmund Poon United Kingdom 10 1.3k 1.6× 457 1.9× 732 3.1× 159 0.7× 199 0.9× 18 1.7k
Christina M. Kochel United States 9 952 1.1× 319 1.3× 644 2.7× 91 0.4× 136 0.6× 15 1.2k

Countries citing papers authored by Ritesh Rathore

Since Specialization
Citations

This map shows the geographic impact of Ritesh Rathore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritesh Rathore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritesh Rathore more than expected).

Fields of papers citing papers by Ritesh Rathore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritesh Rathore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritesh Rathore. The network helps show where Ritesh Rathore may publish in the future.

Co-authorship network of co-authors of Ritesh Rathore

This figure shows the co-authorship network connecting the top 25 collaborators of Ritesh Rathore. A scholar is included among the top collaborators of Ritesh Rathore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritesh Rathore. Ritesh Rathore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somasundar, Ponnandai, et al.. (2020). Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base. Frontiers in Oncology. 10. 568417–568417. 5 indexed citations
2.
3.
4.
Lum, Lawrence G., Archana Thakur, Zaid Al‐Kadhimi, et al.. (2015). Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial. Clinical Cancer Research. 21(10). 2305–2314. 87 indexed citations
5.
Lum, Lawrence G., Archana Thakur, Nicola Kouttab, et al.. (2013). Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: A pilot study. Bone Marrow Transplantation. 49(1). 73–79. 22 indexed citations
6.
Birnbaum, Ariel E., Ritesh Rathore, Priscilla Merriam, et al.. (2012). Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer. American Journal of Clinical Oncology. 37(2). 162–166. 5 indexed citations
7.
8.
Kim, Byung Gon, et al.. (2011). Paraneoplastic Pemphigus (PNP) As a Presenting Finding in a Patient with Hodgkin's Lymphoma. Blood. 118(21). 4864–4864. 1 indexed citations
9.
Rathore, Ritesh, et al.. (2010). Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Advanced Hepatocellular Cancer. American Journal of Clinical Oncology. 33(1). 43–46. 17 indexed citations
10.
Birnbaum, Ariel E., Ritesh Rathore, Harry Wanebo, et al.. (2010). Cetuximab, Paclitaxel, Carboplatin, and Radiation For Head and Neck Cancer. American Journal of Clinical Oncology. 33(2). 144–147. 14 indexed citations
11.
Berz, David, Gerald A. Colvin, Elise McCormack, et al.. (2009). Triple MEL100 Therapy in Multiple Myeloma. Transplantation Proceedings. 41(9). 3863–3867. 1 indexed citations
12.
13.
14.
Colvin, Gerald A., Ritesh Rathore, Lawrence G. Lum, et al.. (2005). The haploimmunostorm syndrome: A distinct clinical entity seen in HLA-mismatched cellular immunotherapy. Biology of Blood and Marrow Transplantation. 11(2). 41–41. 1 indexed citations
15.
Tsai, James, David A. Iannitti, Anna Berkenblit, et al.. (2005). Phase I Study of Docetaxel, Capecitabine, and Carboplatin in Metastatic Esophagogastric Cancer. American Journal of Clinical Oncology. 28(4). 329–333. 9 indexed citations
16.
Safran, Howard, David A. Iannitti, Ramesh K. Ramanathan, et al.. (2004). Herceptin and Gemcitabine for Metastatic Pancreatic Cancers That Overexpress HER-2/neu. Cancer Investigation. 22(5). 706–712. 142 indexed citations
17.
Safran, Howard, Thomas A. DiPetrillo, Ahmed Nadeem, et al.. (2004). Trastuzumab, Paclitaxel, Cisplatin, and Radiation for Adenocarcinoma of the Esophagus: A Phase I Study #. Cancer Investigation. 22(5). 670–677. 46 indexed citations
18.
Lum, Lawrence G., Ritesh Rathore, Frank J. Cummings, et al.. (2003). Phase I/II Study of Treatment of Stage IV Breast Cancer with OKT3 x Trastuzumab–Armed Activated T Cells. Clinical Breast Cancer. 4(3). 212–217. 16 indexed citations
19.
Rathore, Ritesh & Gerald J. Elfenbein. (2003). The chronic leukemias: current and novel therapeutic approaches.. PubMed. 86(8). 240–2. 2 indexed citations
20.
Safran, Howard, Margaret M. Steinhoff, Shamlal Mangray, et al.. (2001). Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 24(5). 496–499. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonid Dubrovsky Breakdown of academic impact, for papers by Martin Kornacker Breakdown of academic impact, for papers by Max M. Wattenberg Breakdown of academic impact, for papers by James G. Jakowatz Breakdown of academic impact, for papers by Dalong Wan Breakdown of academic impact, for papers by Antonio Cubillo Breakdown of academic impact, for papers by Hazel Jones Breakdown of academic impact, for papers by Sylvie Rusakiewicz Breakdown of academic impact, for papers by Edmund Poon Breakdown of academic impact, for papers by Christina M. Kochel
Rankless by CCL
2026